Gloucestershire Hospitals NHS Foundation Trust
Buyer information published with procurement notices.
- Published identifier
- Not supplied
- Address
- Gloucester, UKK1, GL53 7AN, United Kingdom
- First notice
- 29 Jan 2025
- Latest notice
- 8 Oct 2026
Published procurement activity · 109 tenders
Buyer information published with procurement notices.
This modification is to show that the NHS NET CUF uplift of 2.83% has been applied to the price per treatment for both In-Centre and Home Haemodialysis clinical provision. This will apply from 03.12.2025 until 02.12.2026. This will change the lifetime of the contract value if the contract was extended to its maximum term of £
This modification is to show that the NHS NET CUF uplift of 2.83% has been applied to the price per treatment for both In-Centre and Home Haemodialysis clinical provision. This will apply from 03.12.2025 until 02.12.2026. This will change the lifetime of the contract value if the contract was extended to its maximum term of £
Executive Search Proposal - Procurement Business Partners (x2) - Gloucestershire NHS Procurement Shared Service
Executive Search Proposal - Procurement Business Partners (x2) - Gloucestershire NHS Procurement Shared Service
This modification is to show that the NHS NET CUF uplift of 2.83% has been applied to the price per treatment for both In-Centre and Home Haemodialysis clinical provision. This will apply from 03.12.2025 until 02.12.2026. This will change the lifetime of the contract value if the contract was extended to its maximum term of £
This modification is to show that the NHS NET CUF uplift of 2.83% has been applied to the price per treatment for both In-Centre and Home Haemodialysis clinical provision. This will apply from 03.12.2025 until 02.12.2026. This will change the lifetime of the contract value if the contract was extended to its maximum term of £
Gloucestershire hospitals supply of iCare Tonometer Probes
iMEDicare provides a weekly pump clinic to GHFT patients
Provision of Oncotype DX Breast Recurrence Score testing which addresses the issue of overtreatment with chemotherapy, particularly for patients with lymph nod-positive breast cancer.
12 month extension to Systemic Anti Cancer Oncology Services commencing 1st April 2025
Organisation details and tender classifications reflect information published by the original procurement sources. Similar buyer names are grouped only where an official identifier or compatible name and postcode provide a safe link.